Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1955 4
1958 2
1959 2
1961 1
1962 8
1963 10
1964 10
1965 10
1966 10
1967 10
1968 11
1969 15
1970 14
1971 8
1972 7
1973 2
1974 5
1975 16
1976 7
1977 13
1978 9
1979 10
1980 14
1981 12
1982 12
1983 26
1984 18
1985 24
1986 30
1987 21
1988 23
1989 51
1990 30
1991 35
1992 29
1993 30
1994 20
1995 35
1996 26
1997 39
1998 29
1999 39
2000 32
2001 50
2002 44
2003 44
2004 53
2005 59
2006 43
2007 44
2008 49
2009 55
2010 56
2011 58
2012 76
2013 94
2014 91
2015 66
2016 41
2017 62
2018 65
2019 93
2020 111
2021 119
2022 67
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

2,034 results
Results by year
Filters applied: . Clear all
Page 1
Role of acyl-CoA synthetase ACSL4 in arachidonic acid metabolism.
Kuwata H, Hara S. Kuwata H, et al. Among authors: hara s. Prostaglandins Other Lipid Mediat. 2019 Oct;144:106363. doi: 10.1016/j.prostaglandins.2019.106363. Epub 2019 Jul 12. Prostaglandins Other Lipid Mediat. 2019. PMID: 31306767 Review.
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical Trial.
Akamatsu H, Toi Y, Hayashi H, Fujimoto D, Tachihara M, Furuya N, Otani S, Shimizu J, Katakami N, Azuma K, Miura N, Nishino K, Hara S, Teraoka S, Morita S, Nakagawa K, Yamamoto N. Akamatsu H, et al. Among authors: hara s. JAMA Oncol. 2021 Mar 1;7(3):386-394. doi: 10.1001/jamaoncol.2020.6758. JAMA Oncol. 2021. PMID: 33410885 Free PMC article. Clinical Trial.
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).
Sakata Y, Sakata S, Oya Y, Tamiya M, Suzuki H, Shibaki R, Okada A, Kobe H, Matsumoto H, Yokoi T, Sato Y, Uenami T, Saito G, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T. Sakata Y, et al. Among authors: hara s. Eur J Cancer. 2021 Dec;159:144-153. doi: 10.1016/j.ejca.2021.09.041. Epub 2021 Nov 5. Eur J Cancer. 2021. PMID: 34749119
Foreword.
Hara S. Hara S. Biol Pharm Bull. 2022;45(8):978. doi: 10.1248/bpb.b22-ctf4508. Biol Pharm Bull. 2022. PMID: 35908906 Free article. No abstract available.
Total synthesis of cynaropicrin.
Nakamura T, Pitna DB, Kimura K, Yoshimoto Y, Uchiyama T, Mori T, Kondo R, Hara S, Egoshi Y, Yamaguchi S, Suzuki N, Suzuki Y, Usuki T. Nakamura T, et al. Among authors: hara s. Org Biomol Chem. 2021 Jul 21;19(27):6038-6044. doi: 10.1039/d1ob00657f. Epub 2021 May 13. Org Biomol Chem. 2021. PMID: 33982042
Apolipoprotein E-related glomerular disorders.
Saito T, Matsunaga A, Fukunaga M, Nagahama K, Hara S, Muso E. Saito T, et al. Among authors: hara s. Kidney Int. 2020 Feb;97(2):279-288. doi: 10.1016/j.kint.2019.10.031. Epub 2019 Nov 22. Kidney Int. 2020. PMID: 31874799 Free article. Review.
Kidney biopsy guidebook 2020 in Japan.
Ubara Y, Kawaguchi T, Nagasawa T, Miura K, Katsuno T, Morikawa T, Ishikawa E, Ogura M, Matsumura H, Kurayama R, Matsumoto S, Marui Y, Hara S, Maruyama S, Narita I, Okada H, Tsuruya K; Committee of Practical Guide for Kidney Biopsy 2020. Ubara Y, et al. Among authors: hara s. Clin Exp Nephrol. 2021 Apr;25(4):325-364. doi: 10.1007/s10157-020-01986-6. Clin Exp Nephrol. 2021. PMID: 33606126 Free PMC article. No abstract available.
Biological Effects of β-Glucans on Osteoclastogenesis.
Ariyoshi W, Hara S, Koga A, Nagai-Yoshioka Y, Yamasaki R. Ariyoshi W, et al. Among authors: hara s. Molecules. 2021 Apr 1;26(7):1982. doi: 10.3390/molecules26071982. Molecules. 2021. PMID: 33915775 Free PMC article. Review.
2,034 results